INSTITUTE FOR PROTEIN DESIGN

institute-for-protein-design-logo

The mission of the University of Washington Institute for Protein Design is to design a new world of proteins to address 21st century challenges in medicine, energy and technology. The Institute for Protein Design was established in 2012, and is building on strengths within the University of Washington and Seattle more generally. Protein design requires high-level expertise and talent in computing and software, biochemistry, genome sciences, biological structure, pharmacology, immunology and ot... her basic science disciplines, as well as clinical medicine. They are marshaling deep institutional strengths in our faculty, scientific staff, postdoctoral fellows and graduate students, their partners from collaborating institutions, innovator networks, and from the computer and biotechnology industries — bringing extraordinary expertise to bear on a singular focus to advance the potential of protein design. Over the past 16 years, UW researchers have made significant progress in protein design and protein structure prediction, developing the world leading Rosetta software. During this period, UW scientists have developed methods for designing proteins with a wide range of new functions, including catalysts for chemical reactions, HIV and RSV vaccine candidates, and flu virus inhibitors. The IPD integrates these strengths in protein design with Seattle-area expertise in biochemistry, engineering, computer science and medicine, and leverages the exceptional Seattle strength in the software industry.

#SimilarOrganizations #People #Financial #More

INSTITUTE FOR PROTEIN DESIGN

Industry:
Biotechnology Education

Founded:
2012-01-01

Status:
Active

Contact:
206-616-7542

Email Addresses:
[email protected]

Total Funding:
56.3 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache YouTube WordPress 6.0 COVID-19


Similar Organizations

1200-pharma-logo

1200 Pharma

1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.


Current Advisors List

david-baker_image

David Baker Director of the Institute @ Institute for Protein Design
Board_member

Investors List

the-audacious-project_image

The Audacious Project

The Audacious Project investment in Grant - Institute for Protein Design

open-philanthropy-project_image

Open Philanthropy Project

Open Philanthropy Project investment in Grant - Institute for Protein Design

sahsen-ventures_image

Sahsen Ventures

Sahsen Ventures investment in Venture Round - Institute for Protein Design

More informations about "Institute for Protein Design" on Search Engine